Raymond James & Associates Spdr Ser Tr Spdr S&P Biotech E Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Raymond James & Associates holds 383,355 shares of XBI stock, worth $40.2 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
383,355
Previous 355,844
7.73%
Holding current value
$40.2 Million
Previous $33 Million
14.81%
% of portfolio
0.02%
Previous 0.02%
Shares
30 transactions
Others Institutions Holding XBI
# of Institutions
805Shares Held
112MCall Options Held
22.4MPut Options Held
28.8M-
Goldman Sachs Group Inc New York, NY18.1MShares$1.9 Billion0.21% of portfolio
-
Citigroup Inc12.8MShares$1.34 Billion0.54% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A612.1MShares$1.27 Billion2.06% of portfolio
-
Morgan Stanley New York, NY11.4MShares$1.2 Billion0.06% of portfolio
-
Jpmorgan Chase & CO New York, NY10.4MShares$1.09 Billion0.07% of portfolio